{"id":"https://openalex.org/W4389487537","doi":"https://doi.org/10.1016/j.iotech.2023.100536","title":"64O Lenvatinib plus pembrolizumab, pemetrexed, and a platinum (len + pembro + chemo) as first-line therapy for metastatic non squamous non-small cell lung cancer (NSCLC): Phase III LEAP-006 study","display_name":"64O Lenvatinib plus pembrolizumab, pemetrexed, and a platinum (len + pembro + chemo) as first-line therapy for metastatic non squamous non-small cell lung cancer (NSCLC): Phase III LEAP-006 study","publication_year":2023,"publication_date":"2023-12-01","ids":{"openalex":"https://openalex.org/W4389487537","doi":"https://doi.org/10.1016/j.iotech.2023.100536"},"language":"en","primary_location":{"id":"doi:10.1016/j.iotech.2023.100536","doi":"https://doi.org/10.1016/j.iotech.2023.100536","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.iotech.2023.100536","pdf_url":"http://www.esmoiotech.org/article/S2590018823001995/pdf","source":{"id":"https://openalex.org/S4210240197","display_name":"Immuno-Oncology Technology","issn_l":"2590-0188","issn":["2590-0188"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-1","poland-20"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Immuno-Oncology and Technology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://www.esmoiotech.org/article/S2590018823001995/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008593691","display_name":"Roy S. Herbst","orcid":"https://orcid.org/0000-0003-2535-5847","observed_orcids":["https://orcid.org/0000-0003-2535-5847"]},"institutions":[{"id":"https://openalex.org/I2802730090","display_name":"Yale Cancer Center","ror":"https://ror.org/03j7sze86","country_code":"US","type":"facility","lineage":["https://openalex.org/I2802730090","https://openalex.org/I4210117499","https://openalex.org/I4210165192"]},{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]},{"id":"https://openalex.org/I4210165192","display_name":"Smilow Cancer Hospital","ror":"https://ror.org/05q3szf80","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210117499","https://openalex.org/I4210165192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R.S. Herbst","raw_affiliation_strings":["Medical Oncology Department, Yale School of Medicine, Yale Cancer Center, and Smilow Cancer Hospital, New Heaven, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department, Yale School of Medicine, Yale Cancer Center, and Smilow Cancer Hospital, New Heaven, CT, USA","institution_ids":["https://openalex.org/I2802730090","https://openalex.org/I32971472","https://openalex.org/I4210165192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064697305","display_name":"Byoung Chul Cho","orcid":"https://orcid.org/0000-0002-5562-270X","observed_orcids":["https://orcid.org/0000-0002-5562-270X"]},"institutions":[{"id":"https://openalex.org/I193775966","display_name":"Yonsei University","ror":"https://ror.org/01wjejq96","country_code":"KR","type":"education","lineage":["https://openalex.org/I193775966"]},{"id":"https://openalex.org/I4405258038","display_name":"Yonsei Cancer Hospital","ror":"https://ror.org/0005vby86","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I193775966","https://openalex.org/I2799970807","https://openalex.org/I4210160791","https://openalex.org/I4405258038"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"B.C. Cho","raw_affiliation_strings":["Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea","institution_ids":["https://openalex.org/I193775966","https://openalex.org/I4405258038"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024628268","display_name":"Caicun Zhou","orcid":"https://orcid.org/0000-0002-6958-0766","observed_orcids":["https://orcid.org/0000-0002-6958-0766","https://orcid.org/0000-0002-1072-9941"]},"institutions":[{"id":"https://openalex.org/I116953780","display_name":"Tongji University","ror":"https://ror.org/03rc6as71","country_code":"CN","type":"education","lineage":["https://openalex.org/I116953780"]},{"id":"https://openalex.org/I4210127126","display_name":"Shanghai Pulmonary Hospital","ror":"https://ror.org/033nbnf69","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210127126"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"C. Zhou","raw_affiliation_strings":["Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China","institution_ids":["https://openalex.org/I116953780","https://openalex.org/I4210127126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074832020","display_name":"Mauricio Burotto","orcid":"https://orcid.org/0000-0002-7150-4033","observed_orcids":["https://orcid.org/0000-0002-7150-4033"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Burotto","raw_affiliation_strings":["Medical Oncology Dept., Bradford Hill-Clinical Center, Recoleta, Chile"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Dept., Bradford Hill-Clinical Center, Recoleta, Chile","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027946288","display_name":"Manuel Cobo","orcid":"https://orcid.org/0000-0003-3402-1144","observed_orcids":["https://orcid.org/0000-0003-3402-1144"]},"institutions":[{"id":"https://openalex.org/I4210108548","display_name":"Hospital Regional Universitario de M\u00e1laga","ror":"https://ror.org/01mqsmm97","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210108548"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"M. Cobo Dols","raw_affiliation_strings":["Medical Oncology Dept., Hospital Regional Universitario M\u00e1laga Carlos Haya, Malaga, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Dept., Hospital Regional Universitario M\u00e1laga Carlos Haya, Malaga, Spain","institution_ids":["https://openalex.org/I4210108548"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052112651","display_name":"Mehmet Al\u0131 Nah\u0131t \u015eendur","orcid":"https://orcid.org/0000-0001-7021-6139","observed_orcids":["https://orcid.org/0000-0001-7021-6139"]},"institutions":[{"id":"https://openalex.org/I4210150808","display_name":"Ankara Y\u0131ld\u0131r\u0131m Beyaz\u0131t University","ror":"https://ror.org/05ryemn72","country_code":"TR","type":"education","lineage":["https://openalex.org/I4210150808"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"M.A.N. Sendur","raw_affiliation_strings":["Medical Oncology Department, Ankara Yildirim Beyazit Universty - Faculty of Medicine, Ankara, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department, Ankara Yildirim Beyazit Universty - Faculty of Medicine, Ankara, Turkey","institution_ids":["https://openalex.org/I4210150808"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035686789","display_name":"Vladimir Mikhailovich Moiseyenko","orcid":"https://orcid.org/0000-0003-4807-7915","observed_orcids":["https://orcid.org/0000-0003-4807-7915"]},"institutions":[{"id":"https://openalex.org/I4210148464","display_name":"State Budget Institution of Health St. Petersburg Clinical Research Center Specialized Types of Medical Care","ror":"https://ror.org/05ss6ff26","country_code":"RU","type":"healthcare","lineage":["https://openalex.org/I4210148464"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"V. Moiseyenko","raw_affiliation_strings":["Oncology Department, St. Petersburg Clinical Center of Specialized Medical Care, St. Petersburg, Russian Federation"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Department, St. Petersburg Clinical Center of Specialized Medical Care, St. Petersburg, Russian Federation","institution_ids":["https://openalex.org/I4210148464"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012327350","display_name":"Bogdan A. \u017burawski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210137953","display_name":"Centrum Onkologii","ror":"https://ror.org/03vzf8p77","country_code":"PL","type":"healthcare","lineage":["https://openalex.org/I4210137953"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"B. Zurawski","raw_affiliation_strings":["Outpatient Chemotherapy, Prof. Franciszek \u0141ukaszczyk Oncology Centre, Bydgoszcz, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Outpatient Chemotherapy, Prof. Franciszek \u0141ukaszczyk Oncology Centre, Bydgoszcz, Poland","institution_ids":["https://openalex.org/I4210137953"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018480957","display_name":"Ignacio Casarini","orcid":"https://orcid.org/0000-0002-0479-9417","observed_orcids":["https://orcid.org/0000-0002-0479-9417"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"I.A. Casarini","raw_affiliation_strings":["Oncology, Hospital Bernardo Houssay, Buenos Aires, Argentina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology, Hospital Bernardo Houssay, Buenos Aires, Argentina","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078287634","display_name":"Makoto Nishio","orcid":"https://orcid.org/0000-0003-4969-4165","observed_orcids":["https://orcid.org/0000-0003-4969-4165"]},"institutions":[{"id":"https://openalex.org/I4210137039","display_name":"The Cancer Institute Hospital","ror":"https://ror.org/03md8p445","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210137039"]},{"id":"https://openalex.org/I42570316","display_name":"Japanese Foundation For Cancer Research","ror":"https://ror.org/00bv64a69","country_code":"JP","type":"nonprofit","lineage":["https://openalex.org/I42570316"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"M. Nishio","raw_affiliation_strings":["Department of Thoracic Medical Oncology, The Cancer Institute Hospital of JFCR, Koto-ku, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Thoracic Medical Oncology, The Cancer Institute Hospital of JFCR, Koto-ku, Japan","institution_ids":["https://openalex.org/I4210137039","https://openalex.org/I42570316"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004864286","display_name":"Rina Hui","orcid":"https://orcid.org/0000-0003-0696-7442","observed_orcids":["https://orcid.org/0000-0003-0696-7442"]},"institutions":[{"id":"https://openalex.org/I2803024705","display_name":"Westmead Hospital","ror":"https://ror.org/04gp5yv64","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2803024705","https://openalex.org/I4405259172"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"R. Hui","raw_affiliation_strings":["Department of Medical Oncology, Westmead Hospital, Westmead, NSW, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Westmead Hospital, Westmead, NSW, Australia","institution_ids":["https://openalex.org/I2803024705"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010990336","display_name":"Elvire Pons Tostivint","orcid":"https://orcid.org/0000-0003-4478-0523","observed_orcids":["https://orcid.org/0000-0003-4478-0523"]},"institutions":[{"id":"https://openalex.org/I3019204325","display_name":"Centre Hospitalier Universitaire de Nantes","ror":"https://ror.org/05c1qsg97","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019204325"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"E. Pons-Tostivint","raw_affiliation_strings":["Medical Oncology Department, CHU du Nantes - H\u00f4tel-Dieu, Nantes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department, CHU du Nantes - H\u00f4tel-Dieu, Nantes, France","institution_ids":["https://openalex.org/I3019204325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081012352","display_name":"Julia Dudnik","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800633300","display_name":"Soroka Medical Center","ror":"https://ror.org/003sphj24","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2800633300","https://openalex.org/I64767286"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"J. Dudnik","raw_affiliation_strings":["The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka University Medical Center, Beer Sheva, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka University Medical Center, Beer Sheva, Israel","institution_ids":["https://openalex.org/I2800633300"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068874700","display_name":"Syed Zaeem Ahmed","orcid":"https://orcid.org/0009-0005-3690-5375","observed_orcids":["https://orcid.org/0009-0005-3690-5375"]},"institutions":[{"id":"https://openalex.org/I2802445252","display_name":"University Hospitals of Leicester NHS Trust","ror":"https://ror.org/02fha3693","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802445252"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"S. Ahmed","raw_affiliation_strings":["Medical Oncology, University Hospitals of Leicester NHS Trust, Leicester, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, University Hospitals of Leicester NHS Trust, Leicester, UK","institution_ids":["https://openalex.org/I2802445252"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014514185","display_name":"Chinyere E. Okpara","orcid":"https://orcid.org/0000-0002-5621-9138","observed_orcids":["https://orcid.org/0000-0002-5621-9138"]},"institutions":[{"id":"https://openalex.org/I4210148122","display_name":"Eisai (United Kingdom)","ror":"https://ror.org/054j7wb83","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210148122","https://openalex.org/I55881946"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"C.E. Okpara","raw_affiliation_strings":["Oncology Business Group, Eisai Ltd., Hatfield, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Business Group, Eisai Ltd., Hatfield, UK","institution_ids":["https://openalex.org/I4210148122"]}]},{"author_position":"middle","author":{"id":null,"display_name":"L. Yin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L. Yin","raw_affiliation_strings":["BARDS, Merck & Co., Inc., Rahway, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BARDS, Merck & Co., Inc., Rahway, NJ, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102397464","display_name":"Yiwen Luo","orcid":"https://orcid.org/0000-0002-5187-6841","observed_orcids":["https://orcid.org/0000-0002-5187-6841"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Y. Luo","raw_affiliation_strings":["BARDS, Merck & Co., Inc., Rahway, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BARDS, Merck & Co., Inc., Rahway, NJ, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109612120","display_name":"Niyati Bhagwati","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"N. Bhagwati","raw_affiliation_strings":["Global Clinical Development, Merck & Co., Inc., Rahway, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Clinical Development, Merck & Co., Inc., Rahway, NJ, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5055964030","display_name":"Delvys Rodr\u00edguez\u2010Abreu","orcid":"https://orcid.org/0000-0003-0506-1366","observed_orcids":["https://orcid.org/0000-0003-0506-1366"]},"institutions":[{"id":"https://openalex.org/I2799299272","display_name":"Hospital Universitario Insular de Gran Canaria","ror":"https://ror.org/04cbm7s05","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I2799299272","https://openalex.org/I4210120310"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"D. Rodriguez Abreu","raw_affiliation_strings":["Medical Oncology Department, Hospital Universitario Insular de Gran Canaria - Complejo Hospitalario Materno-Insular, Las Palmas de Gran Canaria, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department, Hospital Universitario Insular de Gran Canaria - Complejo Hospitalario Materno-Insular, Las Palmas de Gran Canaria, Spain","institution_ids":["https://openalex.org/I2799299272"]}]}],"institutions":[],"countries_distinct_count":12,"institutions_distinct_count":20,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3020,"currency":"USD","value_usd":3020},"apc_paid":{"value":3020,"currency":"USD","value_usd":3020},"fwci":0.9231,"has_fulltext":true,"cited_by_count":5,"citation_normalized_percentile":{"value":0.76079874,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"20","issue":null,"first_page":"100536","last_page":"100536"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9312000274658203,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9312000274658203,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.060100000351667404,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.00279999990016222,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lenvatinib","display_name":"lenvatinib","score":0.8790000081062317},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":1.0},{"id":"https://openalex.org/keywords/pemetrexed","display_name":"pemetrexed","score":0.9890000224113464},{"id":"https://openalex.org/keywords/platinum-based-chemotherapy","display_name":"platinum-based chemotherapy","score":0.8259999752044678},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.9860000014305115},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.652999997138977}],"concepts":[{"id":"https://openalex.org/C2777240266","wikidata":"https://www.wikidata.org/wiki/Q415220","display_name":"Pemetrexed","level":4,"score":0.7109836935997009},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6313983201980591},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5409437417984009},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4969649612903595},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.4896738827228546},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.4785792827606201},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.4349672794342041},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.262298583984375},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2578132748603821},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.22850418090820312},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.08415880799293518}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.iotech.2023.100536","doi":"https://doi.org/10.1016/j.iotech.2023.100536","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.iotech.2023.100536","pdf_url":"http://www.esmoiotech.org/article/S2590018823001995/pdf","source":{"id":"https://openalex.org/S4210240197","display_name":"Immuno-Oncology Technology","issn_l":"2590-0188","issn":["2590-0188"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-1","poland-20"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Immuno-Oncology and Technology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.iotech.2023.100536","doi":"https://doi.org/10.1016/j.iotech.2023.100536","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.iotech.2023.100536","pdf_url":"http://www.esmoiotech.org/article/S2590018823001995/pdf","source":{"id":"https://openalex.org/S4210240197","display_name":"Immuno-Oncology Technology","issn_l":"2590-0188","issn":["2590-0188"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-1","poland-20"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Immuno-Oncology and Technology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9476000070571899}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8399999737739563}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4389487537.pdf","grobid_xml":"https://content.openalex.org/works/W4389487537.grobid-xml"},"referenced_works_count":1,"referenced_works":["https://openalex.org/W4389487537"],"related_works":["https://openalex.org/W3088933270","https://openalex.org/W4410708315","https://openalex.org/W2947529692","https://openalex.org/W7204800134","https://openalex.org/W4200142029","https://openalex.org/W4389488043","https://openalex.org/W2982147621","https://openalex.org/W4220744355","https://openalex.org/W2807431877","https://openalex.org/W3083362003"],"abstract_inverted_index":{"LEAP-006":[0],"is":[1],"a":[2,44],"2-part":[3],"phase":[4],"3":[5],"study":[6,47],"of":[7,41,48],"len":[8,24,49],"+":[9,11,36,50,52,57,59],"pembro":[10,35,51,58],"chemo":[12,53],"as":[13,27],"first-line":[14],"therapy":[15],"for":[16],"metastatic":[17],"nonsquamous":[18],"NSCLC":[19],"(NCT03829319).":[20],"Part":[21],"1":[22],"established":[23],"8":[25],"mg/d":[26],"the":[28],"recommended":[29],"starting":[30],"dose":[31],"when":[32],"added":[33],"to":[34],"chemo.":[37,60],"We":[38],"present":[39],"results":[40],"part":[42],"2,":[43],"randomized,":[45],"double-blind":[46],"vs":[54],"placebo":[55],"(pbo)":[56]},"counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1}],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2023-12-09T00:00:00"}